Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Patricia Probeck"'
Autor:
Marie Garinot, Fabienne Piras-Douce, Patricia Probeck, Véronique Chambon, Kucku Varghese, Yuanqing Liu, Ernesto Luna, Donald Drake, Jean Haensler
Publikováno v:
International Journal of Pharmaceutics: X, Vol 2, Iss , Pp 100054- (2020)
A structure-activity study was conducted to identify the structural characteristics underlying the adjuvant activity of straight (i.e. non-crosslinked) polyacrylate polymers (PAAs) in order to select a new PAA adjuvant candidate for future clinical d
Externí odkaz:
https://doaj.org/article/c058087f24e54b13820a3efc5985a8b8
Autor:
Ernesto Luna, Donald Drake, Jean Haensler, Yuanqing Liu, Kucku Varghese, Marie Garinot, Fabienne Piras-Douce, Patricia Probeck, Véronique Chambon
Publikováno v:
International Journal of Pharmaceutics: X
International Journal of Pharmaceutics: X, Vol 2, Iss, Pp 100054-(2020)
International Journal of Pharmaceutics: X, Vol 2, Iss, Pp 100054-(2020)
A structure-activity study was conducted to identify the structural characteristics underlying the adjuvant activity of straight (i.e. non-crosslinked) polyacrylate polymers (PAAs) in order to select a new PAA adjuvant candidate for future clinical d
Autor:
François Dalençon, Nicolas Burdin, Véronique Chambon, Fabienne Piras, Shehzad M. Iqbal, Jean-François Cotte, Jean Haensler, Patricia Probeck, Lynn D. Hawkins, Jin Su
Publikováno v:
International journal of pharmaceutics. 486(1-2)
We describe the development, analytical characterization, stability and preclinical efficacy of AF04, a combination adjuvant comprising the synthetic toll-like receptor 4 (TLR4) agonist, E6020, formulated in AF03, a thermoreversible squalene emulsion
Publikováno v:
Journal of pharmaceutical sciences. 103(10)
We have used a protein-based vaccine, a live virus vaccine, and an experimental adjuvant to evaluate the utility of an advanced kinetic modeling approach for stability prediction. The modeling approach uses a systematic and simple procedure for the s
Publikováno v:
Journal of pharmaceutical sciences. 101(12)
AF03 is a squalene‐based emulsion adjuvant that is present in the adjuvanted pandemic influenza vaccine, Humenza™. In this report, we describe the design and development of this novel adjuvant formulation from the selection of the oil and surfact